DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation

Exclusion Criteria

• •History of cerebral vascular accident/transient ischemic attack (CVA/TIA) in last 3 months
• •Cardiac surgery or neurosurgery within 3 months of the intended procedure date
• •Any active bleeding
• •Severe hypersensitivity reaction to ELIQUIS (including drug hypersensitivity, such as skin rash and allergic reactions)
• •Participants cannot have prosthetic heart valves
• •History or bleeding and clotting disorders
• •Contraindications to Aspirin therapy
• •Contraindication to oral anticoagulation
• •Patient on an anticoagulant prior to the ablation for other primary indications like atrial fibrillation (AF), deep vein thrombosis (DVT) or a mechanical valve
• •Evidence of intracardiac thrombus
• •Patient with Creatinine Clearance of \< 30 cc/min
• •Participation in another investigational study related to oral anticoagulation, drug and/or device intervention
• •Claustrophobic patients
• •Implantable Cardioverter Defibrillator (ICD) generator placement before the year 2000
• •Has an ICD and is pacing dependent without underlying rhythm upon interrogation at baseline
• •Patient has abandoned leads
• •Patients who are on p-glycoprotein inducers or inhibitors where the dose of Apixaban cannot be effectively altered